HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2001, 03, 1 (pages: 23 - 28)

Therapeutic effects of paroxetine on the cocaine abuse in heroin addicts

Manna V.

Summary: During the last few years, cocaine abuse has been detected in increasing numbers of heroin addicts taking part in a methadone maintenance programme. Paroxetine, a serotoninergic reuptake blocker, was administered, 20 mg p.o. a day, to 12 outpatients, cocaine abusers with heroin addiction, during a methadone maintenance treatment, to evaluate the possible anti-craving and therapeutic effects of the prescribed drug on cocaine use. Four patients discontinued paroxetine treatment after a few days. Eight patients received paroxetine for at least eight weeks. Cocaine abuse was detected by weekly toxicology screening. After eight weeks of treatment, three patients had completely stopped using cocaine, and four had considerably reduced their consumption. One patient reported no change. So, paroxetine, as suggested for other serotonin reuptake inhibitor drugs, may be considered a safe, effective therapeutic agent in treating of cocaine abuse in heroin addicts.

 

EUROPAD - European Opiate Addiction Treatment Association
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page